Education
About Us
Working with TipRanks
Follow Us
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
PDPL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
PDPL FAQ
What was Parenteral Drugs (India) Limited’s price range in the past 12 months?
Currently, no data Available
What is Parenteral Drugs (India) Limited’s market cap?
Parenteral Drugs (India) Limited’s market cap is $101.08M.
When is Parenteral Drugs (India) Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Parenteral Drugs (India) Limited’s earnings last quarter?
Parenteral Drugs (India) Limited released its earnings results on Feb 14, 2022. The company reported -$11.579 earnings per share for the quarter, missing the consensus estimate of N/A by -$11.579.
Is Parenteral Drugs (India) Limited overvalued?
According to Wall Street analysts Parenteral Drugs (India) Limited’s price is currently Overvalued.
Does Parenteral Drugs (India) Limited pay dividends?
Parenteral Drugs (India) Limited pays a Notavailable dividend of $1.125 which represents an annual dividend yield of N/A. See more information on Parenteral Drugs (India) Limited dividends here
What is Parenteral Drugs (India) Limited’s EPS estimate?
Parenteral Drugs (India) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parenteral Drugs (India) Limited have?
Currently, no data Available
What happened to Parenteral Drugs (India) Limited’s price movement after its last earnings report?
Parenteral Drugs (India) Limited reported an EPS of -$11.579 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Parenteral Drugs (India) Limited?
Currently, no hedge funds are holding shares in IN:PDPL
Company Description
Parenteral Drugs (India) Limited
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
Balaxi Pharmaceuticals Limited
―
Bal Pharma Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Ind-Swift Ltd.
―
Krebs Biochemicals & Industries Ltd.
―